Site 10-113 — Northridge, California

Site 10-113 is a clinical research site located in Northridge, California, United States 91324.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 10-113 has participated in 1 clinical trials.

Therapeutic areas: Alopecia Areata.

Sponsors: AnaptysBio, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Northridge

Browse all research sites in California · View every site in Northridge

• California State University, Northridge, Jacaranda Hall 1578, 1576, 1574
• California State University, Northridge
• Dignity Health Northridge Hospital Medical Center - Nephrology
• The Thomas and Dorothy Leavey Cancer Center Northridge Hospital Medical Center
• CAl State University at Northridge
• Northridge Hospital Medical Center
• California State University, Jacranda Hall 1578, 1576, 1574
• Leavey Cancer Center at Northridge Hospital Medical Center
• University Imaging Centers
• Valley Clinical Trials
• Research Site
• California Medical Research Associates

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 10-113?

Site 10-113 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 10-113 conducted?

Site 10-113 has 1 clinical trials on record. Their work covers Alopecia Areata.

Is Site 10-113 accredited by Crixeo Clinical Trials?

Site 10-113 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 10-113?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.